Journal article icon

Journal article

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.

Abstract:

OBJECTIVE: Therapies that deplete lymphocytes often improve symptoms in patients with otherwise refractory autoimmune disease but may result in long-term lymphopenia, the consequences of which are uncertain. To assess the impact of prolonged lymphopenia on morbidity and mortality, we studied patients who had previously received lymphocytotoxic monoclonal antibody (mAb) therapy for rheumatoid arthritis (RA). METHODS: Fifty-three patients who received the lymphocytotoxic mAb CAMPATH-1H between...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Expand authors...
Journal:
Arthritis and rheumatism
Volume:
44
Issue:
9
Pages:
1998-2008
Publication date:
2001-09-01
DOI:
EISSN:
1529-0131
ISSN:
0004-3591
Source identifiers:
7150

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP